Serevent and Streptococcal sepsis - a phase IV clinical study of FDA data

Summary:

Streptococcal sepsis is reported as a side effect among people who take Serevent (salmeterol xinafoate), especially for people who are female, 60+ old, also take Prilosec, and have Allergic rhinitis.

The phase IV clinical study analyzes which people have Streptococcal sepsis when taking Serevent. It is created by eHealthMe based on reports of 15,422 people who have side effects when taking Serevent from the FDA, and is updated regularly.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.

What is Streptococcal sepsis?

Streptococcal sepsis (whole body inflammation by streptococcal) is found to be associated with 333 drugs and 359 conditions by eHealthMe. Check the latest studies of Streptococcal sepsis.

On Jul, 29, 2026

15,422 people reported to have side effects when taking Serevent.
Among them, 12 people (0.08%) have Streptococcal sepsis.

Could Serevent cause Streptococcal sepsis?

Among these 12 people:

What is the gender of people who have Streptococcal sepsis when taking Serevent? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Streptococcal sepsis when taking Serevent? *

What are other drugs people take besides Serevent? *

What are other side effects people have besides Streptococcal sepsis? *

Inflammation: 11 people, 91.67%
Infective Tenosynovitis (infective inflammation of a tendon sheath): 11 people, 91.67%
Fall: 11 people, 91.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 91.67%
Hepatic Function Abnormal: 11 people, 91.67%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 11 people, 91.67%
Hyperglycemia (high blood sugar): 11 people, 91.67%
Hypokalemia (low potassium): 11 people, 91.67%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 11 people, 91.67%
Weakness: 11 people, 91.67%

What are the existing conditions these people have? *

Type 2 Diabetes: 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Allergic Rhinitis: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Serevent and have Streptococcal sepsis?

- Check whether Streptococcal sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serevent:

Serevent (15,586 reports)

Browse all side effects of Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Streptococcal sepsis:

Streptococcal sepsis (334 drugs)

Browse all the conditions that are associated with Streptococcal sepsis:

Streptococcal sepsis (359 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on salmeterol xinafoate (the active ingredients of Serevent) and Serevent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.